Russian regulatory approval for Gilenya(R) oral MS drug

If it's on your mind and it has to do with multiple sclerosis in any way, post it here.

Russian regulatory approval for Gilenya(R) oral MS drug

Postby MSUK » Fri Sep 10, 2010 12:00 am


Novartis International AG announced Russian regulatory approval for Gilenya(R), a once-daily oral multiple sclerosis therapy and first in a new class processed and transmitted by Hugin AS. The issuer is solely responsible for the content of this announcement.

- Russia is first country to approve Gilenya for the treatment of relapsing remitting MS, the most common form of the disease

- Gilenya is the first disease-modifying treatment in a new drug class and offers significant efficacy with a well-characterized safety tolerability profile

- Action from the US Food and Drug Administration (FDA) on Gilenya is expected in September 2010; other submissions under review worldwide... Read More - ... ageid/1309
User avatar
Family Elder
Posts: 2903
Joined: Wed Oct 14, 2009 3:00 pm


Return to General Discussion


  • Related topics
    Last post

Who is online

Users browsing this forum: No registered users

Contact us | Terms of Service